HydroGraph’s Graphene selected by Hawkeye Bio for use in its early-stage lung cancer detection biosensor
HydroGraph Clean Power has announced that its flagship graphene product, FGA-1, has been successfully trialed in Hawkeye Bio’s biomedical sensor aimed at the early detection of lung cancer. Hawkeye Bio is a clinical stage medical technology company focused on the early detection of cancer.
HydroGraph’s graphene was selected by Hawkeye Bio based on the purity and consistency of its graphene. Headquartered in Toronto, HydroGraph’s manufacturing facility is located in Manhattan, Kan.